1.Hepatocellular carcinoma associated with progressive intrahepatic familial cholestasis type 2: a case report
João Miguel PIMENTEL ; Susana NOBRE ; Rui Caetano OLIVEIRA ; Ricardo MARTINS ; Maria Augusta CIPRIANO
Clinical Transplantation and Research 2024;38(3):241-245
Progressive familial intrahepatic cholestasis type 2 (PFIC2) is an autosomal recessive disorder typically presenting in infancy with cholestasis and rapidly progressing to cirrhosis. PFIC has been associated with an elevated risk of hepatocellular carcinoma (HCC), a neoplasm that is uncommon in children. PFIC type 4 has the strongest link to this type of cancer, although a few cases have also been connected to PFIC2. Herein, we report the case of a 2-year-old boy who underwent liver transplantation due to PFIC2. Histological examination showed cirrhosis and four small HCCs. Over a 20-year period following the transplantation, there was no recurrence of the disease or HCC. Although rare, HCC development can occur in PFIC and may complicate the prognosis. Liver transplantation offers a potential cure for both the metabolic disease and the neoplasm.
2.Evaluation of bioenergetic and mitochondrial function in liver transplantation
Rui Miguel MARTINS ; João Soeiro TEODORO ; Emanuel FURTADO ; Anabela Pinto ROLO ; Carlos Marques PALMEIRA ; José Guilherme TRALHÃO
Clinical and Molecular Hepatology 2019;25(2):190-198
BACKGROUND/AIMS: We measured changes in mitochondrial function and bioenergetics that occur during ischemia/reperfusion in fresh liver samples of patients undergoing liver transplantation. These variations correlated with markers of liver function and clinical outcome. Ischemia/reperfusion injury related to liver transplantation affects mitochondrial function and bioenergetics. Experimental studies were conducted to identify the role of bioenergetics and mitochondrial dysfunction. To the best of our knowledge, no investigation of these two factors’ impacts on liver transplantation has been performed. METHODS: This was a prospective study of 28 patients who underwent liver transplantation. We measured parameters of mitochondrial function and bioenergetics in biopsies performed during the procedure. RESULTS: We observed a statistically significant reduction in mitochondrial membrane potential, an increase in lag phase, and decreases in mitochondrial respiration and adenosine triphosphate content (P<0.010). Higher postoperative aminotransferase peaks correlated with worse mitochondrial function; mitochondrial respiration correlated with arterial lactate (P<0.010). CONCLUSIONS: There is a relationship between mitochondrial function and ischemia/reperfusion injury. The future use of these clinical markers as prognostic factors may allow early identification of post-transplant liver failure and may indicate the need to perform a new transplant.
Adenosine Triphosphate
;
Biomarkers
;
Biopsy
;
Energy Metabolism
;
Humans
;
Ischemia
;
Lactic Acid
;
Liver Extracts
;
Liver Failure
;
Liver Transplantation
;
Liver
;
Membrane Potential, Mitochondrial
;
Mitochondria
;
Prospective Studies
;
Respiration